Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 607-617

  Liu, Bin ^b   Du, Lina ^a,b   Hong, Jau Shyong ^b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NALOXONE; PEROXYNITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG POTENCY; EMBRYO; IMMUNOCYTOCHEMISTRY; MICROGLIA; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEREOISOMERISM;

ANIMALS; CELLS, CULTURED; DOPAMINE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MESENCEPHALON; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NALOXONE; NARCOTIC ANTAGONISTS; NEURONS; NITRATES; NITRITES; OXIDANTS; RATS; RATS, INBRED F344; STEREOISOMERISM; SUBSTANTIA NIGRA; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE;

EID: 0034015558     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Banati RB, Gehrmann J, Schubert P and Kreutzberg GW (1993) Cytotoxicity of microglia. Glia 7:111-118.
2. Beckman JS, Carson M, Smith CD and Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature (Lond) 364:584.
3. Boje KM and Arora PK (1992) Microglia-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256.
4. Bronstein DM, Perez-Otano I, Sun V, Mullis-Sawin SB, Chan J, Wu G-C, Hudson PM, Kong L-Y, Hong J-S and McMillian MK (1995) Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 704:112-116.
5. Casper D, Mytilineou C and Blum M (1991) EGF enhances the survival of dopaminergic neurons in rat embryonic mesencephalon primary cell culture. J Neurosci Res 30:372-381.
6. Chatterjie N, Alexander GJ, Sechzer JA and Lieberman KW (1996) Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity. Neurochem Res 21:691-693.
7. Chatterjie N, Sechzer JA, Lieberman KW and Alexander GJ (1998) Dextro-naloxone counteracts amphetamine-induced hyperactivity. Pharmacol Biochem Behav 59: 271-274.
8. Chao CC, Gekker G, Sheng WS, Hu SX, Tsang M and Peterson PK (1994) Priming effect of morphine on the production of tumor necrosis factor-α by microglia: Implications in respiratory burst activity and human immunedeficiency virus-1 expression. J Pharmacol Exp Ther 269:198-203.
9. Chao CC, Hu S, Molitor TW, Shaskan EG and Peterson PK (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149: 2736-2741.
10. Compston A (1992) Inflammation and the brain. Mol Chem Neuropathol 19:47-63.
11. Crapo JD, McCord JM and Fridovich I (1978) Preparation and assay of superoxide dismutases. Methods Enzymol 53:382-393.
12. Das KP, McMillian MK, Bing G and Hong JS (1995) Modulatory effects of [Met5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures. J Neuroimmunol 62:9-17.
13. Dawson VL, Dawson TM, Uhl GR and Snyder SH (1993) Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90:3256-3259.
14. Dickson DW, Lee SC, Mattiace LA, Yen SH and Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
15. Dunwiddie TV, Perez-Reyes E, Rice KC and Palmer MR (1982) Stereoselectivity of opiate antagonists in rat hippocampus and neocortex: Responses to (+) and (-) isomers of naloxone. Neuroscience 7:1691-1702.
16. Epstein LG (1998) HIV neuropathogenesis and therapeutic strategies. Acta Paediatr Jpn 40:107-111.
17. Faden IA and Salzman S (1992) Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:29-35.
18. Fallis RJ, Fisher M and Lobo RA (1983) A double blind trial of naloxone in the treatment of stroke. Stroke 15:627-629.
19. Friedman L and Mytilineou C (1987) The toxicity of MPTP to dopaminergic neurons in culture is reduced at high concentrations. Neurosci Lett 79:65-72.
20. 15N]nitrate in biological fluids. Anal Biochem 126:131-138.
21. Goodwin DC, Gunther MR, Hsi LC, Crews BC, Eling TE, Mason RP and Marnett LJ (1998) Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385. J Biol Chem 273:8903-8909.
22. Hoffmann JA, Kafatos FC, Janeway CA and Ezekowitz RA (1999) Phylogenetic perspectives in innate immunity. Science (Wash DC) 284:1313-1318.
23. Holaday JW and Macolm DS (1986) Endogenous opioids and their antagonist in endotoxic shock, in 9th International Congress of Infectious and Parasitic Diseases: Bacterial Infection, Antibacterial Chemotherapy (Marget W, Lang W and Gabler-Sanberger E eds) pp 425-435, MMV Medizin, Munich, Germany.
24. Hosobuchi T, Baskin DS and Woo SK (1982) Reversal of induced ischemic neurologic deficit in gerbil by the opiate antagonist naloxone. Science (Wash DC) 215:69-71.
25. Ii M, Sunamoto M, Ohnishi K and Ichimori Y (1996) β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 720:93-100.
26. Iijima I, Minamikawa J-I, Jacobsen AE, Brossi A and Rice KE (1978) Studies in the (+)-morphinin series-5. Synthesis and biological properties of (+)-naloxone. J Med Chem 21:398-400.
27. Jenner P and Olanow W (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47:S161-S170.
28. Jeohn G-H, Kong L-Y, Wilson B, Hudson P and Hong J-H (1998) Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10.
29. Kan MN, Chen YT and Lee AYS (1992) Naloxone reversal of ischemic arrhythmia is stereospecific and suggesting role of endogenous opioid peptides in ischemic heart disease. Proc Soc Exp Biol Med 200:518-521.
30. Kim JP, Goldberg MP and Choi DW (1987) High concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity. Eur J Pharmacol 138:133-136.
31. Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR and Yamamura HI (1995) Molecular biology and pharmacology of cloned opioid receptors. FASEB J 9:516-525.
32. Kong L-Y, McMillian MK, Hudson PM, Jin L and Hong J-S (1997) Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther 280:61-66.
33. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
34. Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM and Hannun YA (1998) Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-α-induced cell death. J Biol Chem 273:11313-11322.
35. Lysle DT and How T (1999) Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes. J Pharmacol Exp Ther 288:502-508.
36. Marcoli M, Ricevuti G, Mazzone A, Pasotti D, Lecchini S and Frigo GM (1989) A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activation. Int J Immunopharmacol 11:57-61.
37. Massey V (1959) The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta 24:255-265.
38. Matyszak MK (1998) Inflammation in the CNS: Balance between immunological privilege and immune responses. Prog Neurobiol 56:19-35.
39. McGeer PL, Itagaki S, Boyes BE and McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291.
40. McGeer PL and McGeer EG (1995) The inflammatory response system of brain: Implications for therapy of Alzeimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195-218.
41. Merrill JE, Koyanagi Y, Zack J, Thomas L. Martin F and Chen IS (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66:2217-2225.
42. Minghetti L and Levi G (1998) Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog Neurobiol 54:99-125.
43. Raine CS (1994) Multiple sclerosis: Immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 53:328-337.
44. Rogers J, Civin WH, Styren SD and McGeer PL (1992) Immune-related mechanisms of Alzheimer's disease pathogenesis, in Alzeimer's Disease, New Treatment Strategies (Khachaturain ZS and Blass JP eds) pp 147-163, Marcel Dekker, New York.
45. Simpkins CO, Ives N, Tate E and Johnson M (1985) Naloxone inhibits superoxide release from human neutrophils. Life Sci 37:1381-1386.